SURVYR

PHR

Phreesia, Inc.
$12.29
−$0.32 (2.54%)Oct 27 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-67%-46%-26%-6%+15%Oct 2025Oct 2026Apr 202652w high $23.8652w low $7.77
PHRSPY
Wall St. Highest PT $19.00 (+54.6%) Wall St. Avg PT $13.93 (+13.4%)
$8$12$17$21$26POC $11Hi $19Avg $14
Underwater Drawdown %Max DD -65.7%Current -47.6%
0.0%-65.7%
Relative Strength vs SPY-61.2% vs SPYUnderperforming
+83%0%-83%
1W
+$0.24 (1.99%)
1M
+$2.14 (21.08%)
3M
+$1.43 (13.17%)
6M
+$2.87 (30.47%)
YTD
−$4.63 (27.36%)
1Y
−$11.18 (47.64%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
15 analysts · mean score 2.00
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$12.29
Average target$13.93
+$1.64 (+13.4%) upsideaverage target vs current price
CurrentAverageMedian
Low$10.00
Median$13.93
High$19.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-12 · Barclays reiterated Equal-Weight on PHR
Downgrade
2026-09-08 · Raymond James downgraded PHR from Outperform to Market Perform
Reiterated
2026-09-04 · DA Davidson reiterated Buy on PHR
Reiterated
2026-09-04 · Baird reiterated Neutral on PHR
Reiterated
2026-09-03 · Freedom Capital Markets reiterated Buy on PHR
Reiterated
2026-09-03 · RBC Capital reiterated Outperform on PHR
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$788.3M
P/E (last 12 months)74.7
P/E (next 12 months, estimated)7.9
52-week range$7.77 – $23.86
Revenue growth (latest quarter vs a year ago)+10.4%
Dividend yieldNo dividend
Analyst consensusBuy (15)
Average analyst price target$13.93 (+13%)

What they do

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions.

Healthcare · Health Information Services
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for PHR yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

PHR earningsNext report in 40 days
Next report
Mon Dec 7, 2026Time not confirmed
EPS consensus$0.36 range $0.28–$0.47
Revenue consensus$128.4M 17 analysts
Last 4 quarters · EPS vs estimate
Sep 2, 2026$0.28est $0.32−14.3%Below estimates
May 27, 2026$0.27est $0.29−6.4%Below estimates
Mar 30, 2026$0.44est $0.32+38.0%Above estimates
Dec 8, 2025$0.31est $0.24+27.9%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-24 11:19:08 ET
24-1225-0325-0525-0925-1226-0326-0526-090.000.44
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-07-31$129.5M+10.4%
2026-04-30$130.9M–
2026-01-31$127.1M–
2025-10-31$120.3M–
2025-07-31$117.3M–

News & catalysts

More news
Phreesia’s Michael Rasbury Named to Becker’s 2026 List of Rising Stars: Healthcare Leaders Under 40
Business Wire · Oct 08
Phreesia to Support Parkinson’s Disease Awareness and Research with The Michael J. Fox Foundation
Business Wire · Oct 06
Phreesia Named to TIME’s 2026 List of the World’s Top HealthTech Companies
Business Wire · Sep 30
Wall Street Splits on Phreesia (PHR) as Margins Improve but Growth Visibility Fades
Insider Monkey · Sep 17
Phreesia’s ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
Business Wire · Sep 14
Rating changes
Reiterated
2026-10-12 · Barclays reiterated Equal-Weight on PHR
Downgrade
2026-09-08 · Raymond James downgraded PHR from Outperform to Market Perform
Reiterated
2026-09-04 · DA Davidson reiterated Buy on PHR
Reiterated
2026-09-04 · Baird reiterated Neutral on PHR
Reiterated
2026-09-03 · Freedom Capital Markets reiterated Buy on PHR
Reiterated
2026-09-03 · RBC Capital reiterated Outperform on PHR

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Linetsky David
President, Network Solutions · 2026-10-22
Buy
$362
Linetsky David
President, Network Solutions · 2026-10-22
Buy
$320
Hoffman Allison C
General Counsel & Secretary · 2026-09-21
Sell
$67.2K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-24 11:19:08 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026